Compare Amgen, Inc. (AMGN) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amgen, Inc. vs PPG Industries, Inc. — how do they compare? Amgen, Inc. trades at $363.55 (market cap $196.12B), while PPG Industries, Inc. trades at $116.76 (market cap $26.03B). The key difference: Amgen, Inc. is far larger — about 7.5× PPG Industries, Inc.'s market cap, and Amgen, Inc. pays the higher dividend (2.77%). Which is the better fit depends on your goals.
| AMGN | PPG | |
|---|---|---|
Market Cap | $196.12B | $26.03B |
Sector | Health | Basic Materials |
52-Week High | $388.16 | $131.56 |
52-Week Low | $271.18 | $94.34 |
Enterprise Value | $241.41B | $32.13B |
Dividend Yield | 2.77% | 2.43% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.
The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.
PPG Industries trades at $116.76, up 0.69% today, with a bearish technical signal despite recent earnings beats. The company maintains strong profitability with a 9.83% net margin and 21.09% ROE, supported by $15.88B in 2025 revenue. Analysts show a 52.63% buy consensus with a $131.75 price target. Recent news highlights innovation in aerospace and marine coatings, though sentiment remains mixed amid modest revenue growth.
PPG offers solid fundamentals and dividend stability but faces headwinds from volume softness and margin pressure. The stock's valuation at a P/E of 16.73 appears reasonable, yet near-term catalysts are limited. Risks include economic sensitivity and competitive pressures, while institutional support and consistent cash flow provide a floor. The outlook is neutral with upside dependent on execution and market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
